Recruiting Major Depressive Disorder Studies in Los Angeles
About Major Depressive Disorder Clinical Trials in Los Angeles
Major depressive disorder (MDD) is a severe form of depression characterized by persistent sadness, loss of interest, and impaired daily functioning. Treatment-resistant depression (TRD) affects patients who do not respond to standard therapies. Novel treatments like ketamine, psilocybin, and neuromodulation are being studied.
There are currently 10 major depressive disorder clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 2,853 participants. Research is being sponsored by Neurocrine Biosciences, Axsome Therapeutics, Inc., Cybin IRL Limited and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Major Depressive Disorder Clinical Trials in Los Angeles — FAQ
Are there major depressive disorder clinical trials in Los Angeles?
Yes, there are 10 major depressive disorder clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What major depressive disorder treatments are being tested?
The 10 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for major depressive disorder.
Data updated October 18, 2026 from ClinicalTrials.gov